| Financial Year |
March 31 2023 |
| Monetary Funds |
1,518,180,437.03 |
| Held-for-trading Financial Assets |
25,061,130.14 |
| Notes Receivable |
19,409,083.26 |
| Accounts Receivable |
38,211,925.49 |
| Advances to Suppliers |
563,041.34 |
| Other Receivables |
911,846.56 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
524,164,522.30 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
65,910,286.53 |
| Total Current Assets |
2,192,412,272.65 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
15,526,419.89 |
| Fixed Assetes |
117,595,593.22 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
142,844,114.79 |
| R&D expenses |
-- |
| Goodwill |
469,600.09 |
| Long-Term Deferred and Prepaid Expenses |
930,164.35 |
| Deferred Income Tax Assets |
9,082,125.39 |
| Other Non-Current Assets |
120,604,253.00 |
| Sub-Total of Non-Current Assets |
1,094,923,931.42 |
| Total Assets |
3,287,336,204.07 |
| Short-Term Loans |
150,000,000.00 |
| Trading Financial liabilities |
21,000.00 |
| Notes Payable |
-- |
| Accounts Payable |
41,601,781.19 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
24,884,104.24 |
| Taxes Payable |
5,453,540.67 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
66,881,678.62 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,739,769.87 |
| Other Current Liabilities |
720,160.20 |
| Sub-Total of Current Liabilities |
303,123,209.95 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
47,054,164.20 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
58,748,534.30 |
| Total Liabilities |
361,871,744.25 |
| Paid-In Capital(Or Share Stock) |
630,726,738.00 |
| Capital Surplus |
394,719,168.39 |
| Surplus Reserve |
182,960,203.80 |
| LESS:Treasury Stock |
11,503,300.00 |
| Undistributed Profits |
1,490,628,141.78 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,925,464,459.82 |
| Owner's Equity（Stockholder's Equity） |
2,925,464,459.82 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,287,336,204.07 |
